glp 1 receptors in the brain GLP-1 for Weight Loss and Diabetes GLP-1 receptor agonists effect on
Description
gratefully acknowledges support from the Simons Foundation
(2021) 22(Suppl 4):e13239
The mechanisms by which pasireotide exerts these effect have been described in the section on Cushings disease
In the landmark STEP-1 clinical trial, participants receiving semaglutide 2.4 mg once weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo
Neither program guarantees that a specific medication will be prescribed
2023;13(5):e12593
